Philip Gardiner PhilipGardiner
8 years ago
Plenary Abstract 839: Dr Schmukler Chicago. Can we use MDHAQ (multi-dimensional) to identify FM? 84% agreement with 2011 FMS questionnaire - so the answer is Yes! (But what is the ‘gold std’?) @RheumNow #FMS #ACR18
D White WIRheum
8 years ago
Checkpoint inhibitors
explosion of papers in 2018
New and/or exacerbated arthritis, myositis, lupus, sarcoidosis, sjogrens, vasculitis
How to treat? - still unknown
Year in review - clinical
#ACR18 @RheumNow
k dao KDAO2011
8 years ago
Risk for infection with TNFi+MTX is NOT increased compared to triple DMARD Rx confirmed in large claims database of commercial insurance #ACR18 @RheumNow abst#218 https://t.co/p25QwUX3ZN
k dao KDAO2011
8 years ago
Plenary session: High dose flu vaccine is safe and has better efficacy than standard flu vaccine in our adult RA patients abst#837 @RheumNow #ACR18 https://t.co/MzAB6mUnHS
Philip Gardiner PhilipGardiner
8 years ago
Q&A 'Over half the GCA patients had LVV+ on PET/CT' [note to self: need to insist on more PET/CT and push for Tocilizumb] #ACR18 @RheumNow #GCA
Philip Gardiner PhilipGardiner
8 years ago
Abst 884 Jeff Sparks. Predictors of ILD in #RA in 1281 patients: High disease activity, seropositivity - no surprises #ACR18 @RheumNow
Philip Gardiner PhilipGardiner
8 years ago
Personal observation here: over 25 years of practice I’ve seen disease activity fall and severe ILD become uncommon - but MTX use much more common. Time to rethink! #Acr18 #RA
Philip Gardiner PhilipGardiner
8 years ago
Abst 2977 Dr Werth Lenabasam - cannabinoid receptor type 2 (CB2) agonist that activates resolution of innate immune responses - effective in reducing interferon beta and gamma in #Dermatomyositis skin biopsies #ACR18
William Shergy WilliamShergy
8 years ago
What’s in a name. Gout by any other name may be better treated. All hail Urate Crystal Arthritis#ACR18@RheumNow Abstract268 https://t.co/iGEENPJM85
William Shergy WilliamShergy
8 years ago
Lisa Sammaritano quoting a patient panel assisting in the development of Reproductive Guidelines for Rheumatology Patients. “My rheumatologist knows me better than my gynecologist.
Olga Petryna DrPetryna
8 years ago
2789 Ph3 Apremilast for Behcet’s oral ulcers: significantly lower number of OU (P≤0.0015) &reduction in OU pain (P≤0.0035) vs PBO at wks 1-12. APR efficacy sustained at wk28: 62% pts achieved complete response of OU &70% relative
reduction in OU pain from BL. #acr18 @rheumnow
Highlights from Tuesday and Wednesday (days 3 and 4) from the ACR annual meeting include: the important and impactful abstracts covered by the Rheumatology Roundup session; upadacitinib clinical trials; and the baricitinib CV and VTE safety analysis.
Dr. Cassie Calabrese: Checkpoint Inhibitors
Dr. Cassie Calabrese gives an overview of irAEs and checkpoint inhibitor therapy studies presented at the ACR/ARHP annual meeting in Chicago.

